Insight Molecular Diagnostics's top three insider shareholders as of June 06, 2026 are Partners, L.P. Broadwood (TenPercentOwner, 12.11Mn shares), Vida Investments, Llc Pura (TenPercentOwner, 10.68Mn shares), Vida Investments, Llc Pura (TenPercentOwner, 8.09Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Alfred D Kingsley | - | 489,111 | 0 | 27 Jun, 2023 |
| Partners, L.P. Broadwood | - | 12,114,700 | 0 | 20 Apr, 2026 |
| Ronald Asbury Andrews | Former Ceo | 583,212 | 0 | 09 Dec, 2022 |
| Mitchell S Levine | Chief Financial Officer | 87,080 | 0 | 15 Mar, 2022 |
| Andrew Arno | - | 0 | 156,084 | 05 Apr, 2023 |
| Andrew J. Last | - | 90,170 | 0 | 27 Jun, 2023 |
| Vida Investments, Llc Pura | - | 0 | 10,682,053 | 29 Apr, 2022 |
| Li Yu | Vp Cntrllr/Prncpl Acctng Offcr | 16,872 | 0 | 19 May, 2022 |
| Melinda Griffith | - | 30,000 | 0 | 17 Aug, 2022 |
| Jennifer L. Carter | - | 30,500 | 0 | 17 Aug, 2022 |
| Gisela Paulsen | Former President And Coo | 366,500 | 0 | 20 Dec, 2022 |
| Douglas T. Ross | Former Cso | 234,114 | 0 | 22 Dec, 2022 |
| Anish M. John | Chief Financial Officer | 150,000 | 0 | 17 Aug, 2022 |
| John Peter Gutfreund | - | 715,000 | 1,075,000 | 05 Apr, 2023 |
| Josh Riggs | Ceo And President | 38,365 | 0 | 30 Mar, 2026 |
| Andrea S. James | Chief Financial Officer | 151,231 | 0 | 11 Feb, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Apr, 2026 | Partners, L.P. Broadwood | Common Stock, no par value | A | 102,057 | $3.45 | 12,033,896 | D | P |
| 17 Apr, 2026 | Partners, L.P. Broadwood | Common Stock, no par value | A | 40,114 | $3.57 | 12,074,010 | D | P |
| 20 Apr, 2026 | Partners, L.P. Broadwood | Common Stock, no par value | A | 40,690 | $3.88 | 12,114,700 | D | P |
| 26 Mar, 2026 | Josh Riggs | Common Stock | A | 47,170 | - | 50,675 | D | M |
| 26 Mar, 2026 | Josh Riggs | Common Stock | A | 47,170 | - | 50,675 | D | M |
| 26 Mar, 2026 | Josh Riggs | Common Stock | A | 47,170 | - | 50,675 | D | M |
| 26 Mar, 2026 | Josh Riggs | Common Stock | D | 12,310 | $4.11 | 38,365 | D | F |
| 26 Mar, 2026 | Josh Riggs | Common Stock | D | 12,310 | $4.11 | 38,365 | D | F |
| 26 Mar, 2026 | Josh Riggs | Common Stock | D | 12,310 | $4.11 | 38,365 | D | F |
| 26 Mar, 2026 | Josh Riggs | Restricted Stock Units | D | 47,170 | $0.00 | 141,509 | D | M |
| 26 Mar, 2026 | Josh Riggs | Restricted Stock Units | D | 47,170 | $0.00 | 141,509 | D | M |
| 26 Mar, 2026 | Josh Riggs | Restricted Stock Units | D | 47,170 | $0.00 | 141,509 | D | M |
| 10 Feb, 2026 | Partners, L.P. Broadwood | Common Stock, no par value | A | 521,739 | $5.75 | 11,931,839 | D | P |
| 28 Sep, 2025 | Josh Riggs | Option to Purchase Common Stock | A | 400,000 | $0.00 | 400,000 | D | A |
| 28 Sep, 2025 | Josh Riggs | Option to Purchase Common Stock | A | 400,000 | $0.00 | 400,000 | D | A |
| 28 Sep, 2025 | Josh Riggs | Option to Purchase Common Stock | A | 400,000 | $0.00 | 400,000 | D | A |
| 01 Jul, 2025 | Andrew Arno | Common Stock, no par value | A | 55,000 | $0.00 | 136,554 | D | A |
| 26 Mar, 2025 | Josh Riggs | Restricted Stock Units | A | 188,679 | $0.00 | 188,679 | D | A |
| 26 Mar, 2025 | Josh Riggs | Restricted Stock Units | A | 188,679 | $0.00 | 188,679 | D | A |
| 26 Mar, 2025 | James Yang Liu | Option to Purchase Common Stock | A | 10,000 | $0.00 | 10,000 | D | A |